Act Venture Capital

ACT Venture Capital, established in 1994, stands as a prominent and long-standing venture capital firm based in Dublin, Ireland. Recognized as a leader in the Irish venture ecosystem, the firm has cultivated a strong reputation for identifying and nurturing high-growth technology companies. With over €500 million under management across multiple funds, ACT has played a pivotal role in the development of Ireland's tech landscape over nearly three decades.

The firm primarily focuses on early-stage investments, typically engaging with companies from the Seed to Series A stages. ACT's investment thesis centers on disruptive technology businesses across a diverse range of sectors, including enterprise software, fintech, medtech, and deep tech. Their strategic approach involves not only providing capital but also offering significant operational support and strategic guidance to help portfolio companies scale globally. To date, ACT Venture Capital has invested in over 100 companies, demonstrating a broad and active engagement within the startup community.

ACT Venture Capital typically deploys initial checks ranging from €1 million to €5 million, with the capacity for substantial follow-on investments to support companies through subsequent growth rounds, potentially up to €10 million. This flexible investment strategy allows them to back promising ventures from inception through significant scaling phases. The firm boasts a strong track record of successful exits, including notable acquisitions such as Decawave, a fabless semiconductor company acquired by Qorvo for $400 million, SilverCloud Health, a leading digital mental health platform acquired by Amwell, and Movidius, a computer vision company acquired by Intel. These exits underscore ACT's ability to identify and back companies that achieve significant market impact and generate strong returns.